Page 9 of 12
The Journal of Organic Chemistry
1
2
3
4
5
2-(4-Bromophenyl)-3-(1-phenylvinyl)-1-tosylaziridine (8ac):
1328, 1161, 1089, 911, 812, 776, 707; HRMS (ESI) calcd for
oil (45%, 81 mg), Rf = 0.57 (petroleum ether/ethyl acetate = 5:1)
C24H24NO2S+ [M+H]+ m/z 390.1522 , found 390.1514.
1
was synthesized according to General Procedure C; H NMR
2-([1,1'-Biphenyl]-4-yl)-3-(1-phenylvinyl)-1-tosylaziridine
(8ag): oil (58%, 105 mg) was synthesized according to General
Procedure C; 1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 8.2 Hz),
7.67 (d, J = 8.2 Hz), 7.62 – 7.17 (m), 5.60 (s, 1H trans), 5.46 –
5.40 (m, 2H trans and cis), 5.29 (s, 1H cis), 4.29 (d, J = 7.2 Hz,
1H cis), 4.25 (d, J = 4.7 Hz, 1H trans), 4.02 – 3.97 (m, 2H trans
and cis), 2.45 (s, 3H cis), 2.40 (s, 3H trans); 13C{1H} NMR (100
MHz, CDCl3) δ 145.1, 144.3, 142.1, 141.1, 141.1, 140.8, 140.7,
138.6, 137.7, 137.4, 131.4, 130.2, 129.7, 129.2, 129.0, 128.9,
128.7, 128.5, 128.5, 128.4, 128.0, 127.9, 127.7, 127.5, 127.5,
127.3, 126.9, 126.5, 126.1, 116.5, 116.2, 51.4, 49.2, 48.5, 47.3,
22.0, 21.9; IR (KBr) ν (cm-1): 3030, 2922, 1598, 1328, 1162,
1089, 912, 812, 763, 696; HRMS (ESI) calcd for C29H26NO2S+
[M+H]+ m/z 452.1679, found 452.1674.
(400 MHz, CDCl3) δ 7.91 (d, J = 8.2 Hz), 7.65 (d, J = 8.2 Hz),
7.48 (d, J = 8.4 Hz), 7.44 – 7.15 (m), 7.05 (d, J = 8.3 Hz), 5.58
(s, 1H trans), 5.42 (s, 1H cis), 5.39 (s, 1H trans), 5.22 (s, 1H
cis), 4.18 (d, J = 7.2 Hz, 1H cis), 4.14 (d, J = 4.5 Hz, 1H trans),
3.97 (d, J = 7.2 Hz, 1H cis), 3.91 (d, J = 4.7 Hz, 1H trans), 2.44
(s, 3H cis), 2.40 (s, 3H trans); 13C{1H} NMR (100 MHz, CDCl3)
δ 144.5, 141.2, 138.5, 137.2, 132.0, 131.6, 131.4, 130.8, 130.3,
129.8, 129.7, 128.9, 128.8, 128.6, 128.5, 128.3, 127.9, 126.4,
125.9, 123.4, 116.5, 116.4, 50.6, 49.4, 48.4, 46.7, 22.0, 21.9; IR
(KBr) ν (cm-1): 3057, 2923, 1597, 1492, 1397, 1328, 1161, 911,
813, 707; HRMS (ESI) calcd for C23H21BrNO2S+ [M+H]+ m/z
454.0471, found 454.0477.
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
2-(4-Fluorophenyl)-3-(1-phenylvinyl)-1-tosylaziridine (8ad):
oil (41%, 65 mg), Rf = 0.57 (petroleum ether/ethyl acetate =
1
2-(Naphthalen-2-yl)-3-(1-phenylvinyl)-1-tosylaziridine
(8ah): oil (56%, 96 mg), Rf = 0.46 (petroleum ether/ethyl
acetate = 5:1), was synthesized according to General Procedure
5:1), was synthesized according to General Procedure C; H
NMR (400 MHz, CDCl3) δ 7.92 (d, J = 8.2 Hz), 7.65 (d, J = 8.2
Hz), 7.48 – 7.12 (m), 7.05 (t, J = 8.6 Hz), 6.86 (t, J = 8.7 Hz),
5.57 (s, 1H trans), 5.41 (s, 1H cis), 5.38 (s, 1H trans), 5.21 (s,
1H cis), 4.22 (d, J = 7.2 Hz, 1H cis), 4.18 (d, J = 4.7 Hz, 1H
trans), 3.97 – 3.91 (m, 2H trans and cis), 2.46 (s, 3H cis), 2.41
(s, 3H trans); 13C{1H} NMR (100 MHz, CDCl3) δ 164.6, 162.1,
145.2, 144.4, 141.4, 138.5, 137.9, 137.6, 137.4, 131.2, 131.1,
130.2, 129.8, 129.6, 128.9, 128.7, 128.6, 128.5, 128.4, 128.2,
127.9, 126.5, 125.98, 116.5, 116.2, 116.0, 115.8, 115.4, 115.2,
51.0, 49.2, 48.5, 46.6, 22.0, 21.9; 19F NMR (376 MHz, CDCl3)
δ -112.34, -113.96; IR (KBr) ν (cm-1): 2920, 1599, 1513, 1446,
1328, 1162, 1088, 913, 816, 707; HRMS (ESI) calcd for
C23H21FNO2S+ [M+H]+ m/z 394.1272, found 394.1278.
1
C; H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 8.3 Hz), 7.87 –
7.17 (m), 7.13 (d, J = 8.1 Hz), 5.64 (s), 5.50 (s, 1H trans), 5.39
(s, 1H trans), 5.31 (s, 1H cis), 4.40 (d, J = 7.2 Hz), 4.30 (d, J =
4.4 Hz, 1H trans), 4.15 (d, J = 4.7 Hz, 1H trans), 4.04 (d, J =
7.2 Hz, 1H cis), 2.44 (s, 3H cis), 2.35 (s, 3H trans); 13C{1H}
NMR (100 MHz, CDCl3) δ 144.3, 141.5, 138.7, 137.3, 133.7,
133.3, 130.2, 129.9, 129.7, 129.1, 128.9, 128.7, 128.6, 128.5,
128.4, 128.3, 128.1, 128.0, 127.5, 127.0, 126.8, 126.5, 126.5,
126.4, 126.2, 126.1, 125.6, 116.5, 116.4, 51.6, 49.5, 48.6, 47.7,
22.0, 21.9; IR (KBr) ν (cm-1): 3054, 2916, 1598, 1446, 1328,
1162, 1088, 912, 815, 707; HRMS (ESI) calcd for C27H24NO2S+
[M+H]+ m/z 426.1522, found 426.1529.
2-(1-Phenylvinyl)-1-tosyl-3-(4-
2-(4-Methoxyphenyl)-3-(1-phenylvinyl)-1-tosylaziridine
(8ai): oil (29%, 47 mg), Rf = 0.66 (petroleum ether/ethyl acetate
= 3:1), was synthesized according to General Procedure C; 1H
NMR (400 MHz, CDCl3) δ 7.92 (d, J = 8.3 Hz), 7.65 (d, J = 8.3
Hz), 7.47 – 7.19 (m), 7.12 (d, J = 8.7 Hz), 6.89 (d, J = 8.7 Hz),
6.73 – 6.68 (m), 5.54 (s, 1H cis), 5.42 (s, 1H trans), 5.36 (s, 1H
cis), 5.25 (s, 1H trans), 4.24 (d, J = 4.8 Hz, 1H trans), 4.20 (d,
J = 7.2 Hz, 1H cis), 3.92 (d, J = 7.2 Hz, 1H cis), 3.89 (d, J = 4.7
Hz, 1H trans), 3.82 (s, 3H cis), 3.71 (s, 3H trans), 2.44 (s, 3H
trans), 2.40 (s, 3H cis); 13C{1H} NMR (100 MHz, CDCl3) δ
160.4, 159.7, 145.0, 144.2, 141.9, 138.5, 138.2, 137.8, 137.6,
135.3, 130.9, 130.1, 129.7, 129.2, 128.9, 128.7, 128.5, 128.3,
127.9, 126.4, 126.1, 124.3, 123.8, 116.3, 115.6, 114.2, 113.7,
55.6, 55.5, 52.3, 48.5, 48.4, 47.2; IR (KBr) ν (cm-1): 2921, 1598,
1496, 1328, 1161, 1090, 912, 803, 707; HRMS (ESI) calcd for
C24H24NO3S+ [M+H]+ m/z 406.1471, found 406.1478.
(trifluoromethyl)phenyl)aziridine (8ae): oil (45%, 80 mg), Rf
= 0.60 (petroleum ether/ethyl acetate = 5:1), was synthesized
according to General Procedure C; 1H NMR (400 MHz, CDCl3)
δ 7.93 (d, J = 7.9 Hz), 7.66 (d, J = 7.9 Hz), 7.58 (m), 7.45 – 7.17
(m), 5.63 (s, 1H trans), 5.44 (s, 1H trans), 5.42 (s, 1H cis), 5.23
(s, 1H cis), 4.27 (d, J = 7.3 Hz, 1H cis), 4.15 (d, J = 4.6 Hz, 1H
trans), 4.06 – 3.98 (m, 2H trans and cis), 2.46 (s, 3H cis), 2.40
(s, 3H trans); 13C{1H} NMR (100 MHz, CDCl3) δ 145.4, 144.6,
140.9, 138.5, 137.7, 137.3, 137.1, 137.0, 134.9, 131.1, 130.3,
129.8, 129.4, 128.9, 128.8, 128.6, 128.6, 128.4, 128.4, 128.0,
126.5, 125.9, 125.9, 125.8, 125.8, 125.8, 116.8, 116.6, 50.1,
50.0, 48.5, 46.6, 22.1, 21.9; 19F NMR (376 MHz, CDCl3) δ -
62.64, -62.69; IR (KBr) ν (cm-1) 2921, 1597, 1494, 1328, 1162,
1088, 928, 802; HRMS (ESI) calcd for C24H21F3NO2S+ [M+H]+
m/z 444.1240, found 444.1248
2-(1-Phenylvinyl)-3-(p-tolyl)-1-tosylaziridine (8af): oil (57%,
89 mg), Rf = 0.46 (petroleum ether/ethyl acetate = 5:1), was
2-(4-(Methylthio)phenyl)-3-(1-phenylvinyl)-1-tosylaziridine
(8aj): oil (39%, 66 mg), Rf = 0.67 (petroleum ether/ethyl acetate
= 3:1), was synthesized according to General Procedure C; 1H
NMR (400 MHz, CDCl3) δ 7.92 (d, J = 8.2 Hz), 7.65 (d, J = 8.2
Hz), 7.45 – 7.16 (m), 7.08 (m), 5.56 (s, 1H trans), 5.42 (s), 5.38
(s, 1H trans), 5.25 (s), 4.22 – 4.17 (m, 2H trans and cis), 3.95
(d, J = 7.2 Hz, 1H cis), 3.90 (d, J = 4.8 Hz, 1H trans), 2.48 (s,
3H trans), 2.44 (s, 3H cis), 2.40 (s, 3H trans), 2.38 (s, 3H cis);
13C{1H} NMR (100 MHz, CDCl3) δ 145.1, 144.3, 141.5, 140.1,
138.7, 138.5, 138.0, 137.6, 137.4, 135.1, 130.2, 129.8, 129.7,
129.0, 128.9, 128.7, 128.5, 128.5, 128.4, 128.3, 127.91, 126.4,
126.4, 126.1, 126.0, 116.4, 116.0, 51.6, 48.9, 48.5, 47.2, 22.0,
21.9, 15.8, 15.8; IR (KBr) ν (cm-1): 2973, 2933, 1606, 1445,
1
synthesized according to General Procedure C; H NMR (400
MHz, CDCl3) δ 7.95 – 7.89 (m), 7.65 (d, J = 8.1 Hz), 7.47 –
7.12 (m), 7.08 (d, J = 7.9 Hz), 6.97 (d, J = 7.9 Hz), 5.55 (s, 1H
trans), 5.41 (s, 1H cis), 5.37 (s, 1H trans), 5.26 (s, 1H cis), 4.27
– 4.18 (m, 2H trans and cis), 3.97 – 3.88 (m, 2H trans and cis),
2.43 (s, 3H cis), 2.39 (s, 3H trans), 2.36 (s, 3H trans), 2.22 (s,
3H cis); 13C{1H} NMR (100 MHz, CDCl3) δ 145.0, 144.2, 141.7,
139.1, 138.6, 138.2, 138.0, 137.7, 137.6, 135.2, 130.1, 129.7,
129.5, 129.3, 129.2, 129.2, 129.0, 128.8, 128.7, 128.5, 128.3,
127.9, 126.4, 126.1, 116.3, 115.9, 52.0, 48.8, 48.4, 47.5, 22.0,
21.9, 21.6, 21.4; IR (KBr) ν (cm-1): 3030, 2922, 1598, 1446,
ACS Paragon Plus Environment